Stratagene, Hycor Issue Second Amended Registration Statement | GenomeWeb

NEW YORK, April 16 (GenomeWeb News) - Hycor and Stratagene have filed an amended registration statement with the US Securities and Exchange Commission about their proposed merger. It is the second amended statement the companies have issued since they announced plans to merge in July 2003.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.